Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder

Source: International Journal of Nanomedicine - Category: Nanotechnology Tags: Journal of Experimental Pharmacology Source Type: research